盐酸埃克替尼治疗EGFR突变状态明确的晚期非小细胞肺癌的临床观察

BACKGROUND AND OBJECTIVE: Icotinib is the first self-developed small molecular drug in China for targeted therapy of lung cancer. Compared to the other two commercially available epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, gefitinib and erlotinib, icotinib is similar to them...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Zhongguo Fei Ai Za Zhi
Format: Artigo
Sprog:Inglês
Udgivet: 中国肺癌杂志编辑部 2015
Fag:
临床研究
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6015183/
https://ncbi.nlm.nih.gov/pubmed/26706949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2015.12.04
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker